Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE)
EUR 45.28
(1.71%)
EUR 45.28
(1.71%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 246.09 Million EUR | 10.72% |
| 2022 | 222.26 Million EUR | 23.18% |
| 2021 | 180.43 Million EUR | 2.44% |
| 2020 | 176.14 Million EUR | -1.32% |
| 2019 | 178.49 Million EUR | 5.8% |
| 2018 | 168.7 Million EUR | 21.7% |
| 2017 | 138.63 Million EUR | 0.5% |
| 2016 | 137.93 Million EUR | -1.51% |
| 2015 | 140.04 Million EUR | 10.05% |
| 2014 | 127.25 Million EUR | 8.64% |
| 2013 | 117.13 Million EUR | -2.38% |
| 2012 | 119.99 Million EUR | 3.27% |
| 2011 | 116.19 Million EUR | 4.59% |
| 2010 | 111.09 Million EUR | 9.56% |
| 2009 | 101.39 Million EUR | 41.59% |
| 2008 | 71.61 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 41.79 Million EUR | 17.61% |
| 2004 | 35.53 Million EUR | 21.68% |
| 2003 | 29.2 Million EUR | -6.47% |
| 2002 | 31.22 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 67.61 Million EUR | 8.7% |
| 2024 Q2 | 77.8 Million EUR | 15.06% |
| 2024 Q3 | 70.1 Million EUR | -9.9% |
| 2023 FY | 246.09 Million EUR | 10.72% |
| 2023 Q4 | 62.2 Million EUR | -5.62% |
| 2023 Q3 | 65.91 Million EUR | 9.78% |
| 2023 Q2 | 60.03 Million EUR | 3.63% |
| 2023 Q1 | 57.93 Million EUR | -0.51% |
| 2022 Q1 | 49.89 Million EUR | 0.97% |
| 2022 FY | 222.26 Million EUR | 23.18% |
| 2022 Q4 | 58.23 Million EUR | 1.83% |
| 2022 Q2 | 56.94 Million EUR | 14.13% |
| 2022 Q3 | 57.18 Million EUR | 0.43% |
| 2021 FY | 180.43 Million EUR | 2.44% |
| 2021 Q1 | 44.16 Million EUR | -10.33% |
| 2021 Q2 | 45.33 Million EUR | 2.67% |
| 2021 Q3 | 41.52 Million EUR | -8.41% |
| 2021 Q4 | 49.41 Million EUR | 18.99% |
| 2020 Q3 | 43.27 Million EUR | 10.55% |
| 2020 FY | 176.14 Million EUR | -1.32% |
| 2020 Q1 | 44.47 Million EUR | -1.79% |
| 2020 Q4 | 49.24 Million EUR | 13.8% |
| 2020 Q2 | 39.14 Million EUR | -12.0% |
| 2019 Q3 | 44.15 Million EUR | -2.95% |
| 2019 Q2 | 45.49 Million EUR | 4.48% |
| 2019 Q1 | 43.54 Million EUR | -3.01% |
| 2019 FY | 178.49 Million EUR | 5.8% |
| 2019 Q4 | 45.28 Million EUR | 2.57% |
| 2018 Q2 | 45.28 Million EUR | 26.72% |
| 2018 FY | 168.7 Million EUR | 21.7% |
| 2018 Q4 | 44.89 Million EUR | 4.94% |
| 2018 Q1 | 35.73 Million EUR | -6.47% |
| 2018 Q3 | 42.78 Million EUR | -5.52% |
| 2017 Q1 | 37.62 Million EUR | 8.17% |
| 2017 FY | 138.63 Million EUR | 0.5% |
| 2017 Q4 | 38.2 Million EUR | 7.31% |
| 2017 Q3 | 35.6 Million EUR | 30.95% |
| 2017 Q2 | 27.19 Million EUR | -27.74% |
| 2016 FY | 137.93 Million EUR | -1.51% |
| 2016 Q2 | 34.26 Million EUR | -4.33% |
| 2016 Q3 | 33.06 Million EUR | -3.5% |
| 2016 Q1 | 35.81 Million EUR | -4.03% |
| 2016 Q4 | 34.78 Million EUR | 5.19% |
| 2015 Q3 | 33.7 Million EUR | -3.66% |
| 2015 FY | 140.04 Million EUR | 10.05% |
| 2015 Q4 | 37.32 Million EUR | 10.74% |
| 2015 Q2 | 34.98 Million EUR | 2.77% |
| 2015 Q1 | 34.04 Million EUR | -1.91% |
| 2014 Q2 | 31.22 Million EUR | 1.7% |
| 2014 Q1 | 30.7 Million EUR | -0.99% |
| 2014 FY | 127.25 Million EUR | 8.64% |
| 2014 Q3 | 30.62 Million EUR | -1.91% |
| 2014 Q4 | 34.7 Million EUR | 13.3% |
| 2013 FY | 117.13 Million EUR | -2.38% |
| 2013 Q1 | 26.5 Million EUR | -17.83% |
| 2013 Q2 | 28.8 Million EUR | 8.67% |
| 2013 Q3 | 30.82 Million EUR | 7.01% |
| 2013 Q4 | 31 Million EUR | 0.61% |
| 2012 FY | 119.99 Million EUR | 3.27% |
| 2012 Q1 | 29.24 Million EUR | -10.27% |
| 2012 Q3 | 29.85 Million EUR | 4.21% |
| 2012 Q4 | 32.25 Million EUR | 8.06% |
| 2012 Q2 | 28.64 Million EUR | -2.04% |
| 2011 Q4 | 32.58 Million EUR | 17.08% |
| 2011 FY | 116.19 Million EUR | 4.59% |
| 2011 Q3 | 27.83 Million EUR | 1.1% |
| 2011 Q2 | 27.53 Million EUR | -2.53% |
| 2011 Q1 | 28.24 Million EUR | -5.99% |
| 2010 Q4 | 30.04 Million EUR | 6.68% |
| 2010 FY | 111.09 Million EUR | 9.56% |
| 2010 Q1 | 25.7 Million EUR | 9.04% |
| 2010 Q2 | 27.18 Million EUR | 5.76% |
| 2010 Q3 | 28.16 Million EUR | 3.61% |
| 2009 Q2 | 28.04 Million EUR | 15.34% |
| 2009 Q1 | 24.31 Million EUR | 0.0% |
| 2009 FY | 101.39 Million EUR | 41.59% |
| 2009 Q4 | 23.57 Million EUR | -7.47% |
| 2009 Q3 | 25.47 Million EUR | -9.15% |
| 2008 FY | 71.61 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 41.79 Million EUR | 17.61% |
| 2004 FY | 35.53 Million EUR | 21.68% |
| 2003 FY | 29.2 Million EUR | -6.47% |
| 2002 FY | 31.22 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| aap Implantate AG | 11.47 Million EUR | -2044.032% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 92.705% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 92.705% |
| elexxion AG | 443.88 Thousand EUR | -55340.611% |
| Geratherm Medical AG | 22.3 Million EUR | -1003.508% |
| Koninklijke Philips N.V. | 18.16 Billion EUR | 98.646% |
| Stratec SE | 261.91 Million EUR | 6.04% |
| Siemens Healthineers AG | 22.36 Billion EUR | 98.9% |